How COVID-19 induces cytokine storm with high mortality

Abstract

The newly emerging coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, but has rapidly spread all over the world. Some COVID-19 patients encounter a severe symptom of acute respiratory distress syndrome (ARDS) with high mortality. This high severity is dependent on a cytokine storm, most likely induced by the interleukin-6 (IL-6) amplifier, which is hyper-activation machinery that regulates the nuclear factor kappa B (NF-κB) pathway and stimulated by the simultaneous activation of IL-6-signal transducer and activator of transcription 3 (STAT3) and NF-κB signaling in non-immune cells including alveolar epithelial cells and endothelial cells. We hypothesize that IL-6-STAT3 signaling is a promising therapeutic target for the cytokine storm in COVID-19, because IL-6 is a major STAT3 stimulator, particularly during inflammation. We herein review the pathogenic mechanism and potential therapeutic targets of ARDS in COVID-19 patients.

Cited by papers we hold 12

• Safety of pathogenetic therapy for multiple sclerosis during the COVID-19 pandemic · 2022
  Not checked
• RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation · 2021
  No notice
• Thymus Degeneration and Regeneration · 2021
  Not checked
• The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases · 2021
  No notice
• The Role of Th17 Response in COVID-19 · 2021
  No notice
• The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease · 2021
  Corrected
• Induction of trained immunity by influenza vaccination - impact on COVID-19 · 2021
  No notice
• COVID-19: breaking down a global health crisis · 2021
  No notice
• Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2 · 2021
  No notice
• Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019 · 2020
  Not checked
• NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients · 2020
  No notice
• Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.